Altrafin AG’s Estee Lauder EL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-21,340
Closed -$3.12M 60
2023
Q4
$3.12M Sell
21,340
-525
-2% -$69.7K 1.2% 31
2023
Q3
$3.16M Buy
21,865
+11,570
+112% +$1.93M 1.38% 29
2023
Q2
$2.02M Buy
+10,295
New +$2.18M 0.91% 33
2022
Q4
Sell
-1,675
Closed -$362K 74
2022
Q3
$362K Buy
1,675
+145
+9% +$37K 0.22% 64
2022
Q2
$390K Buy
1,530
+61
+4% +$15.5K 0.21% 65
2022
Q1
$400K Sell
1,469
-6,731
-82% -$2.03M 0.16% 74
2021
Q4
$3.04M Buy
+8,200
New +$2.78M 1.1% 32

Other funds holding EL

Altrafin AG's EL Position: Q1 2024 in Review

Altrafin AG sold out of Estee Lauder (EL) in Q1 2024, closing a stake of 21,340 shares — an estimated $3.12M sold.

Altrafin AG first reported a position in EL in Q4 2021 and held it in 7 quarters. The position peaked at $3.16M in Q3 2023. 1,060 funds tracked by Wall St. Rank hold EL as of Q1 2024.

  • Altrafin AG reported no remaining Estee Lauder position as of Q1 2024 after selling out during the quarter.
  • Altrafin AG sold 21,340 Estee Lauder shares in Q1 2024, an estimated $3.12M.
  • Altrafin AG first reported a position in Estee Lauder in Q4 2021 and held it in 7 quarters.
  • Altrafin AG's Estee Lauder position peaked at $3.16M in Q3 2023.
  • 1,060 funds tracked by Wall St. Rank held Estee Lauder as of Q1 2024.

Based on Altrafin AG's 13F filing for Q1 2024, filed 17 Feb 2026.